3-Hydroxypyrimidine-2,4-Diones as Novel Hepatitis B Virus Antivirals Targeting the Viral Ribonuclease H

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00245-17
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

3-Hydroxypyrimidine-2,4-Diones as Selective Active Site Inhibitors of HIV Reverse Transcriptase-Associated RNase H: Design Synthesis, and Biochemical Evaluations

English

3-Hydroxypyrimidine-2,4-Diones as Selective Active Site Inhibitors of HIV Reverse Transcriptase-Associated RNase H: Design Synthesis, and Biochemical Evaluations

English

Direct-Acting Antivirals and Host-Targeting Agents Against the Hepatitis a Virus

Journal of Clinical and Translational Hepatology
2015English

Treating Hepatitis B Virus/Hepatitis C Virus Coinfected Patients With Direct-Acting Hepatitis C Virus Antivirals Only Is Not Safe

Hepatology
MedicineHepatology
2016English

Novel Chimeric Protein as Therapeutic Vaccine Against Hepatitis B Virus

International Journal of Bioscience, Biochemistry and Bioinformatics
2013English

Direct‐Acting Antivirals in Hepatitis C Virus‐Associated Diffuse Large B‐cell Lymphomas

Oncologist
Cancer ResearchMedicineOncology
2018English

Basic Salt‐Lake Brine: An Efficient Catalyst for the Transformation of CO 2 Into Quinazoline‐2,4(1 H ,3 H )‐diones

ChemSusChem
Environmental ChemistryEnergyChemical EngineeringMaterials Science
2018English

Direct Acting Antivirals for the Treatment of Chronic Viral Hepatitis

Scientifica
AgriculturalEnvironmental ScienceBiological Sciences
2012English

Coinfection With Hepatitis B and Hepatitis C Virus: New Insights of Treatment in the Era of Direct Acting Antivirals.

International Journal of Advanced Research
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy